Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9–59 years: A randomized, double-blind, controlled, phase IV clinical trial

Authors

Tian Feng (ORCID: https://orcid.org/0000-0002-1797-8262)
Chenyan Zhao (ORCID: https://orcid.org/0000-0002-1807-314X)
Qinghu Guan
Shiguang Lei (ORCID: https://orcid.org/0009-0004-6217-5399)
Yuwei Li (ORCID: https://orcid.org/0000-0002-5488-242X)
Xiaoyu Li (ORCID: https://orcid.org/0000-0001-6778-7862)
Dan Yu (ORCID: https://orcid.org/0000-0002-1720-3432)
Jieru Wang (ORCID: https://orcid.org/0000-0002-7984-4550)
Siliang Zhou
Hu Chen (ORCID: https://orcid.org/0009-0007-7635-0030)
Yuanxue Gao
Xue Tan
Xinyi Yang (ORCID: https://orcid.org/0009-0000-4943-5492)

Institutions

Sinovac Biotech (CN)
Guizhou Center for Disease Control and Prevention (CN)
National Institutes for Food and Drug Control (CN)

Publication Details

Journal: Vaccine
Published: 2024-08-01
DOI: https://doi.org/10.1016/j.vaccine.2024.126182
Citations: 1
Primary Topic: Influenza Virus Research Studies
Type: article
Field-Weighted Citation Impact: 0.39

Funders

Henan Provincial Key Laboratory of Medical Polymer Materials Technology and Application, Tuoren Medical Device Co., Ltd.

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9–59 years: A randomized, double-blind, controlled, phase IV clinical trial

Tian Feng, Chenyan Zhao, Qinghu Guan, Shiguang Lei et al.

Aug 1, 2024

1 citations

Vaccine

Influenza Virus Research Studies

0.39

article

Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9–59 years: A randomized, double-blind, controlled, phase IV clinical trial

Tian Feng, Chenyan Zhao, Qinghu Guan, Shiguang Lei, Yuwei Li, Xiaoyu Li, Dan Yu, Jieru Wang, Siliang Zhou, Hu Chen, Yuanxue Gao, Xue Tan, Xinyi Yang

August 1, 2024article en

1 citations

Abstract

No abstract available for this paper.

VaccineVol. 42(21)

Sinovac Biotech (CN), Guizhou Center for Disease Control and Prevention (CN), National Institutes for Food and Drug Control (CN)

Henan Provincial Key Laboratory of Medical Polymer Materials Technology and Application, Tuoren Medical Device Co., Ltd.

Openalex Percentile: Top 35%

Influenza Virus Research Studies

0.39

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9–59 years: A randomized, double-blind, controlled, phase IV clinical trial — Tian Feng, Chenyan Zhao, et al. · Vaccine (2024) | TGRS Research Map | TGRS